Thanks, Shai. I'll review highlights of our Q4 results and provide our expectations for Q1 and the full year 2025 and then we'll take some questions. In short, our Q4 financial results were exemplary across the board and kept a very strong year for Lemonade. We remain very much on track with our ambitious goals for positive EBITDA by the end of next year, loss ratio tracking to target consistently accelerating topline growth with little change in fixed overhead expenses and very favorable cash flow dynamics. Q4 brought our best ever loss ratio, helping to drive a near doubling of gross profit in 2024. In force premium grew 26% to $944 million, while customer count increased by 20% to 2.4 million. Premium per customer increased 5% versus the prior year to $388, driven primarily by rate increases. Annual dollar retention or ADR was 86% down one percentage point since this time last year. This slight sequential decline in year-on-year decline is not unexpected given our efforts to reduce less profitable portions of our home book in the second half of 2024. These efforts likely dampened our ADR by about three percentage points. Gross earned premium in Q4 increased 25% as compared to the prior year to $226 million, in line with IFP growth. Revenue in Q4 increased 29% from the prior year to $149 million. The growth in revenue was driven by the increase in gross earned premium, a slightly higher effective ceding commission rate under our quota share reinsurance structure and a 32% increase in investment income. Our gross loss ratio was 63% for Q4 as compared to 77% in Q4 2023 and 73% in Q3 2024. Excluding the total impact of CATs in Q4, which was roughly one percentage point, our gross loss ratio ex-CAT was 62%. Total gross prior period development had a roughly 5% favorable impact with a negligible portion of that driven by CAT. We saw this favorable prior period development across all products with the exception of our pet product line. On a net basis, prior period development had a roughly 7% favorable impact, of which, approximately 1% was from CAT. Trailing 12-months, our TTM loss ratio was about 73% or 12 points better year-on-year and four points better sequentially. All of these insurance metrics and more are included in our insurance supplement that you'll find at the end of our Shareholder Letter. Gross profit increased 90% as compared to the prior year, driven primarily by premium growth and significant loss ratio improvement. While adjusted gross profit increased 88%, driven by premium growth and loss ratio improvement. Operating expense excluding loss and loss adjustment expense increased 38% to $124 million in Q4 as compared to the prior year, driven primarily by an increase in growth spend. Other insurance expense grew 35% in Q4 versus the prior year, slightly ahead of the growth of earned premium. Total sales and marketing expense increased by $23 million or 95%, primarily due to increased growth spend of approximately $23 million and a modest customer support expense increase. Total growth spend in the quarter was $36 million, more than double the $13 million in the prior quarter. Full year growth spend more than doubled in 2024 from $55 million to $122 million. We continue to utilize our Synthetic Agents growth funding program and have continued to finance 80% of our growth spend. As a reminder, you'll see 100% of our growth spend flow through the P&L as always, while the impact of the growth mechanism is visible on the cash flow statement and the balance sheet. And the net financing to date is about $83 million as of December 31. Technology development expense was up just 3% year-on-year to $22 million, while G&A expense increased 16% as compared to the prior year to $34 million, primarily due to increasing interest expense from our financing agreements. Personnel expense and headcount control continue to be a high priority. Total headcount is down about 2% as compared to the prior year at 1,235, while the topline IFP again grew fully 26%. Net loss was $30 million in Q4 or a loss of $0.42 per share as compared to a net loss of $42 million or $0.61 per share in the prior year. Adjusted EBITDA loss was $24 million in Q4 versus an EBITDA loss of $29 million in the prior year. Our total cash, cash equivalents, and investments ended the quarter at approximately $1 billion, up $42 million versus the prior quarter and up $76 million for the full year, showing a continuing positive net cash flow trend. With these metrics in mind, I'll outline our specific financial expectations for the first quarter and the full year 2025. From a growth spend perspective, we expect to invest roughly $35 million in Q1 to generate profitable customers with a healthy lifetime value. This amount will likely increase in both Q2 and Q3 and then may decline somewhat in Q4 to a level similar to the Q1 growth spend rate, totaling roughly $165 million for the year. This expected quarterly spend pattern is similar to what we've seen in prior years. For the first quarter of 2025, we expect in force premium of between $997 million and $1 billion. Gross earned premium of between $229 million and $231 million, revenue of between $143 million and $145 million and adjusted EBITDA loss of between $49 million and $46 million, this does include an approximately $20 million expected impact from the California Wildfires. Without that fire impact, that guidance would be as a result about $20 million better. Stock-based compensation expense of approximately $18 million, capital expenditures of approximately $2 million and a weighted average share count of approximately 73 million shares. And for the full year 2025, we expect in force premium at year end of between $1.203 billion and $1.208 billion, gross earned premium of between $1.025 billion and $1.028 billion, revenue between $655 million and $657 million and adjusted EBITDA loss of between $140 million and $135 million, this also includes that same $20 million is expected to be a headwind from the California Wildfires mentioned in the Q1 figures. Also expect stock-based compensation expense for the full year of approximately $60 million, capital expenditures of approximately $10 million and a weighted average share count for the full year of approximately 74 million shares. And with that, I would like to hand things back over to Shai to answer some questions from our retail investors.